Quality from Home: Remote Review
Rachel Walker, David Schumacher, and Staci Loughney
Working from home is becoming an increasingly widespread practice, and FDA regulated industry is no exception. Even post-pandemic, it is likely that some staff in many companies will continue to work remotely for various logistical reasons. Some study activities must be observed in-person, but it is possible for quality assurance personnel to conduct a portion of study audits virtually. This poster will discuss auditing different types of data remotely, advantages and disadvantages of a work-from-home setup for quality assurance personnel, and the practical equipment and personnel commitments necessary to streamline the process.
